/

Sociétés

Am

Non vérifié

AmacaThera Inc.

Ce que nous écrivons

BiologieÉconomieIndustrie pharmaceutiqueSanté PubliqueStart-up

3 communiqués de presse

Voir tous les communiqués de presse

08/04/2025

Industrie pharmaceutique

Santé Publique

Biologie

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel(TM)

Source

AmacaThera Inc.

Émetteur

1.00

0

Press Release cover image

08/01/2025

Industrie pharmaceutique

Santé Publique

Économie

Management

Organisation d'Entreprise

Biologie

Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies

Source

AmacaThera Inc.

Émetteur

1.00

0

Press Release cover image

20/11/2024

Industrie pharmaceutique

Santé Publique

AmacaThera Announces Phase 1 Results of First-in-Human Study with AMT-143, Exceeding Expectations and Paving the Way for a Novel Approach to Post-Operative Pain Relief

Source

AmacaThera Inc.

Émetteur

1.00

0

Followers

0

Compatibilité

0